Form 4: J.C. Flowers Entities Execute Significant Pre-Planned Sale of Jefferson Capital Shares

Key insiders, including J.C. Flowers IV L.P. and JCF IV Coinvest JCAP L.P., have completed a pre-planned sale of over 8.7 million shares of Jefferson Capital, Inc. common stock at $15 per share.

Summary

• J.C. Flowers IV L.P. and JCF IV Coinvest JCAP L.P., both 10% owners and affiliated with a director of Jefferson Capital, Inc. (JCAP), disposed of a combined 8,708,911 shares of common stock.
• The transactions occurred on June 27, 2025, with shares sold at a price of $15 per share.
• The sales were conducted pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.
• Following these transactions, J.C. Flowers IV L.P. indirectly beneficially owns 13,492,856 shares, and JCF IV Coinvest JCAP L.P. indirectly beneficially owns 30,228,952 shares.
• The total indirect beneficial ownership by these two entities after the reported transactions is 43,721,808 shares.
• J. Christopher Flowers, who controls JCF Associates IV Ltd., is deemed to control the entities involved in the sale and disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the substantial insider selling by significant beneficial owners and director-affiliated entities. While the sale is pre-planned under Rule 10b5-1, the sheer volume of shares disposed can still signal a lack of confidence or a belief that the stock is fully valued, potentially leading to negative market reaction.

Negatives

• The sale represents a significant reduction in the holdings of key insider entities, which can be perceived negatively by the market, potentially signaling a belief that the stock is fully valued or that insiders are diversifying their portfolios.
• The large volume of shares sold (over 8.7 million) could exert downward pressure on the stock price, even if pre-planned.

Risks

• Potential negative market perception due to substantial insider selling, which could lead to a decrease in investor confidence.
• Increased supply of shares in the market from the sale could put downward pressure on Jefferson Capital, Inc.'s stock price.
• While pre-planned under Rule 10b5-1(c), the sale still indicates a reduction in exposure by significant beneficial owners.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on the insider transaction.

Industry Context

Insider sales, particularly by significant shareholders and directors, are closely monitored by the market as they can provide insights into management's or large investors' perspectives on the company's valuation and future prospects. While pre-planned sales under Rule 10b5-1 are common for diversification or liquidity, large volumes can still attract scrutiny.

Comparison to Industry Standards

• Not directly applicable for a Form 4 filing, which reports individual insider transactions rather than company performance metrics. However, large insider sales, even if pre-planned, are generally viewed with caution by investors across all industries as they represent a reduction in insider alignment with shareholder interests.

Related Party Transactions

• The transactions involve J.C. Flowers IV L.P. and JCF IV Coinvest JCAP L.P., which are related entities controlled by J. Christopher Flowers, who is also a director and 10% owner of Jefferson Capital, Inc. This constitutes a related party transaction in the context of insider dealings.

Stakeholder Impact

• Shareholders: May react negatively to the significant insider selling, potentially leading to a decrease in share price due to concerns about insider confidence or increased supply of shares.
• Employees, Customers, Suppliers, Creditors: No direct impact is indicated by this specific filing, as it pertains solely to share ownership changes.

Key Dates

Recommendation

Keywords

Jefferson Capital, JCAP, insider sale, Form 4, beneficial ownership, J.C. Flowers, stock transaction, Rule 10b5-1